. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 22;184(3):927–935. doi: 10.1007/s10549-020-05903-z

Table 4.

Prognostic association between hepcidin and (i) time to distant recurrence, as well as (ii) time to death due to any cause with an interaction term for BMI *Interaction p-value

Model	Outcome	Time to distant recurrence		Time to death due to any cause
		Hazard ratio (95% confidence interval)	p-value	Hazard ratio (95% confidence interval)	p-value
	Hepcidin (continuous) (75th vs. 25th percentile)
Uni-variable	BMI > 30	1.81 (1.06–3.10)	< 0.01^*	1.91 (1.13–3.22)	0.03^*
	BMI ≤ 30	0.80 (0.59–1.09)		0.98 (0.72–1.33)
	Hepcidin (continuous) (75th vs. 25th percentile)
Multi-variable	BMI > 30	1.84 (1.04–3.25)	0.02^*	1.58 (0.91–2.72)	0.11^*
	BMI ≤ 30	0.92 (0.67–1.28)		0.97 (0.69–1.37)

Interaction p-value